X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
hematology (28) 28
index medicus (27) 27
female (25) 25
male (23) 23
aged (20) 20
middle aged (18) 18
adult (13) 13
aged, 80 and over (10) 10
oncology (9) 9
lymphomas (8) 8
multiple myeloma (8) 8
netherlands (8) 8
treatment outcome (8) 8
chemotherapy (7) 7
survival (7) 7
analysis (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
therapy (6) 6
trial (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
comorbidity (5) 5
lymphoma (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
patients (5) 5
prognosis (5) 5
b-cell lymphoma (4) 4
biopsy (4) 4
cancer (4) 4
care and treatment (4) 4
cohort studies (4) 4
cyclophosphamide - adverse effects (4) 4
diagnosis (4) 4
diffuse large b-cell lymphoma (4) 4
drug therapy (4) 4
follow-up studies (4) 4
guidelines (4) 4
kaplan-meier estimate (4) 4
lymphocytes b (4) 4
mortality (4) 4
myelodysplastic syndrome (4) 4
relapse (4) 4
retrospective studies (4) 4
rituximab (4) 4
angiogenesis (3) 3
antibodies, monoclonal, murine-derived - adverse effects (3) 3
article (3) 3
bone-marrow (3) 3
cancer patient (3) 3
case report (3) 3
chronic myeloid leukemia (3) 3
chronic myeloid-leukemia (3) 3
cohort analysis (3) 3
conference abstract (3) 3
controlled study (3) 3
cyclophosphamide - administration & dosage (3) 3
development and progression (3) 3
diffuse large b‐cell lymphoma (3) 3
doxorubicin - adverse effects (3) 3
health aspects (3) 3
human (3) 3
journal article (3) 3
lenalidomide (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
lymphoma, large b-cell, diffuse - pathology (3) 3
multicenter (3) 3
netherlands - epidemiology (3) 3
obinutuzumab (3) 3
overall survival (3) 3
phase-ii (3) 3
population (3) 3
population-based (3) 3
prednisone - adverse effects (3) 3
prospective studies (3) 3
registries (3) 3
risk factors (3) 3
rituximab - administration & dosage (3) 3
stem cell transplantation (3) 3
stem cells (3) 3
transplantation (3) 3
vincristine - adverse effects (3) 3
yes (3) 3
young adult (3) 3
acute myeloid leukaemia (2) 2
adolescent (2) 2
age (2) 2
anticoagulants - administration & dosage (2) 2
anticoagulants - adverse effects (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
autografts (2) 2
autologous stem-cell transplantation (2) 2
azacitidine (2) 2
b-cells (2) 2
blood (2) 2
bone lesion (2) 2
bortezomib (2) 2
cancer survival (2) 2
ceruloplasmin - deficiency (2) 2
ceruloplasmin - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Medical Case Reports, ISSN 1752-1947, 12/2014, Volume 8, Issue 1
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5503 - 5503
Introduction Bone lesions are one of the primary symptoms in multiple myeloma (MM), and it has been suggested that these lesions adversely impact overall... 
Journal Article
Histopathology, ISSN 0309-0167, 12/2017, Volume 71, Issue 6, pp. 960 - 971
Journal Article
European Journal of Haematology, ISSN 0902-4441, 04/2018, Volume 100, Issue 4, pp. 367 - 371
OBJECTIVES: The monitoring of response in chronic myeloid leukemia (CML) is of great importance to identify patients failing their treatment in order to adjust... 
d_article_not_yet_freely_accessible | Journal Article | myeloproliferative neoplasms | philadelphia chromosome | molecular cytogenetics | HEMATOLOGY | Cytogenetics | Development and progression | Chronic myeloid leukemia | Myeloid leukemia | Invasiveness | Leukemia | Bone marrow | Sampling | Patients
Journal Article
JOURNAL OF PATHOLOGY, ISSN 0022-3417, 07/2015, Volume 236, Issue 3, pp. 302 - 314
Journal Article
Cancer Epidemiology, ISSN 1877-7821, 2017, Volume 48, pp. 110 - 116
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1860 - 1860
Abstract Introduction Chronic lymphocytic leukemia (CLL) is characterized by a profound immune suppression. In addition, CLL cells evade immune destruction by... 
Journal Article
HEMATOLOGICAL ONCOLOGY, ISSN 0278-0232, 04/2018, Volume 36, Issue 2, pp. 416 - 421
Journal Article